Biolife Solutions Inc. | Small-cap | Healthcare
$25.91
3.31%
| Biolife Solutions Stock Comparison:
Biolife Solutions vs Intuitive SurgicalBiolife Solutions vs Becton, DickinsonBiolife Solutions vs AtriCureBiolife Solutions vs Staar SurgicalBiolife Solutions vs AzentaBiolife Solutions vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 23.9M
Gross Profit 15.8M 65.94%
Operating Income -1.2M -5.09%
Net Income -448.0K -1.87%
EPS (Diluted) $-0.01

Balance Sheet Metrics

Total Assets 395.1M
Total Liabilities 42.5M
Shareholders Equity 352.6M
Debt to Equity 0.12

Cash Flow Metrics

Operating Cash Flow 6.0M
Free Cash Flow 1.6M

Revenue & Profitability Trend

Biolife Solutions Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i82.3M143.3M161.8M119.2M48.1M
Cost of Goods Sold i28.6M96.5M107.9M82.1M20.6M
Gross Profit i53.7M46.8M53.8M37.0M27.4M
Gross Margin % i65.3%32.6%33.3%31.1%57.1%
Operating Expenses
Research & Development i7.9M18.8M14.8M11.8M6.7M
Selling, General & Administrative i50.2M80.3M69.2M47.7M21.7M
Other Operating Expenses i-----
Total Operating Expenses i58.1M99.1M84.0M59.5M28.4M
Operating Income i-7.1M-57.5M-39.9M-30.6M-4.0M
Operating Margin % i-8.7%-40.2%-24.7%-25.7%-8.3%
Non-Operating Items
Interest Income i----58.0K
Interest Expense i-----
Other Non-Operating Income-3.6M-6.9M-104.2M2.1M2.7M
Pre-tax Income i-11.4M-66.3M-144.8M-29.0M-1.3M
Income Tax i-38.0K169.0K-5.0M-20.1M-3.3M
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-20.2M-66.4M-139.8M-8.9M2.0M
Net Margin % i-24.5%-46.4%-86.4%-7.5%4.1%
Key Metrics
EBITDA i5.6M-37.1M81.5M-19.6M-1.6M
EPS (Basic) i$-0.44$-1.52$-3.29$-0.22$0.09
EPS (Diluted) i$-0.44$-1.52$-3.29$-0.22$0.03
Basic Shares Outstanding i4606707343719185424810273850394427306258
Diluted Shares Outstanding i4606707343719185424810273850394427306258

Income Statement Trend

Biolife Solutions Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i95.4M35.4M19.4M69.9M90.4M
Short-term Investments i9.2M16.3M43.3M0-
Accounts Receivable i9.2M18.7M33.9M23.2M8.0M
Inventory i29.0M43.5M34.9M28.3M11.6M
Other Current Assets6.0M6.8M6.9M4.7M-
Total Current Assets i148.8M120.6M138.5M126.1M114.7M
Non-Current Assets
Property, Plant & Equipment i14.7M31.4M36.1M35.8M19.8M
Goodwill i434.2M470.6M481.6M601.6M147.9M
Intangible Assets i9.6M21.1M32.1M152.1M31.0M
Long-term Investments-----
Other Non-Current Assets6.5M7.7M9.1M9.8M4.7M
Total Non-Current Assets i250.7M292.1M311.8M428.2M120.1M
Total Assets i399.5M412.7M450.2M554.3M234.8M
Liabilities
Current Liabilities
Accounts Payable i3.6M6.9M15.4M14.9M3.7M
Short-term Debt i12.5M10.0M4.8M3.8M1.7M
Current Portion of Long-term Debt-----
Other Current Liabilities--2.2M5.1M5.8M
Total Current Liabilities i32.7M42.2M44.6M42.7M15.6M
Non-Current Liabilities
Long-term Debt i17.7M32.7M38.9M23.1M9.4M
Deferred Tax Liabilities i124.0K188.0K250.0K5.5M0
Other Non-Current Liabilities--2.3M4.9M4.6M
Total Non-Current Liabilities i17.8M32.9M41.5M33.5M14.0M
Total Liabilities i50.6M75.1M86.0M76.2M29.6M
Equity
Common Stock i47.0K45.0K43.0K42.0K33.0K
Retained Earnings i-335.1M-313.3M-246.9M-107.1M-97.4M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i348.9M337.7M364.2M478.0M205.2M
Key Metrics
Total Debt i30.2M42.7M43.7M26.9M11.2M
Working Capital i116.0M78.4M93.9M83.4M99.1M

Balance Sheet Composition

Biolife Solutions Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-20.2M-66.4M-139.8M-8.9M2.0M
Depreciation & Amortization i8.7M12.3M16.5M12.9M5.1M
Stock-Based Compensation i30.9M31.7M25.3M14.0M6.0M
Working Capital Changes i-2.9M-2.0M-18.2M-2.4M-2.6M
Operating Cash Flow i16.9M-31.4M-122.6M-5.7M9.7M
Investing Activities
Capital Expenditures i-3.2M-6.4M-10.4M-8.4M-4.6M
Acquisitions i60.4M001.6M-15.9M
Investment Purchases i-18.4M-27.1M-53.1M0-1.0M
Investment Sales i21.9M56.2M8.9M00
Investing Cash Flow i58.6M17.8M-58.1M-13.2M-24.7M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i0020.0M1.6M3.2M
Debt Repayment i-6.6M-498.0K-2.2M-31.8M-2.2M
Financing Cash Flow i-7.0M10.1M16.0M-35.7M100.6M
Free Cash Flow i4.9M-18.9M-18.9M-13.0M2.0M
Net Change in Cash i68.5M-3.5M-164.7M-54.6M85.6M

Cash Flow Trend

Biolife Solutions Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -58.89
Forward P/E -90.29
Price to Book 3.48
Price to Sales 12.96
PEG Ratio 2.21

Profitability Ratios

Profit Margin -5.92%
Operating Margin -4.41%
Return on Equity -5.66%
Return on Assets -0.80%

Financial Health

Current Ratio 4.43
Debt to Equity 6.86
Beta 1.76

Per Share Data

EPS (TTM) $-0.40
Book Value per Share $7.26
Revenue per Share $1.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
blfs1.2B-58.893.48-5.66%-5.92%6.86
Intuitive Surgical 168.4B65.359.4416.04%28.51%0.00
Becton, Dickinson 56.4B35.952.216.18%7.41%75.93
AtriCure 1.8B-39.393.82-7.85%-7.27%16.63
Staar Surgical 1.4B49.734.07-25.55%-42.45%12.04
Azenta 1.4B-10.240.82-9.15%-16.68%3.15

Financial data is updated regularly. All figures are in the company's reporting currency.